Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

Strategic Review Update

26th Nov 2025 17:00

RNS Number : 1151J
Litigation Capital Management Ltd
26 November 2025
 

Litigation Capital Management Limited

("LCM" or the "Company")

Strategic Review Update

As announced on 15 September 2025, the Board has been undertaking a formal review of the Company's strategic options, supported by its independent financial adviser, Luminis Partners. The review continues to progress well, with constructive engagement underway with a number of credible counterparties.

The Company is continuing to evaluate a range of potential strategic options, each considered against the status quo of a transition to a run-off model. Based on the progress made to date, the Board notes that the strategic review has the potential to deliver a transaction that could represent a viable alternative for the Company and its shareholders relative to the status quo.

The Company is in regular contact with its secured lender regarding the strategic review, and the secured lender has provided support to date for the progress of the strategic review in the form of covenant relief.

However, shareholders are advised that there is no certainty that any transaction will materialise. The Board will only recommend a transaction if it considers it to be in the best interests of the Company and its stakeholders.

The Company will provide a further update in due course and as appropriate, in accordance with its disclosure obligations.

Enquiries

 

Litigation Capital Management

Patrick Moloney, Chief Executive Officer

David Collins, Chief Financial Officer

 

 

Cavendish (Nomad and Broker)

Tel: 020 7220 0500

Jonny Franklin-Adams and Isaac Hooper (Corporate Finance)

Tim Redfern (Corporate Broking)

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
UPDFLFSLLFLRFIE

Related Shares:

Litigation Cap.
FTSE 100 Latest
Value9,691.58
Change82.05